Titlebook: Das Ovarialkarzinom; 1 Tumorbiologie, Scr Hans-Gerhard Meerpohl,Albrecht Pfleiderer,Christia Book 1993 Springer-Verlag Berlin Heidelberg 19

Capricious

書目名稱Das Ovarialkarzinom影響因子(影響力)




書目名稱Das Ovarialkarzinom影響因子(影響力)學(xué)科排名




書目名稱Das Ovarialkarzinom網(wǎng)絡(luò)公開度




書目名稱Das Ovarialkarzinom網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Das Ovarialkarzinom被引頻次




書目名稱Das Ovarialkarzinom被引頻次學(xué)科排名




書目名稱Das Ovarialkarzinom年度引用




書目名稱Das Ovarialkarzinom年度引用學(xué)科排名




書目名稱Das Ovarialkarzinom讀者反饋




書目名稱Das Ovarialkarzinom讀者反饋學(xué)科排名

Glaci冰

https://doi.org/10.1007/978-1-349-02612-8t an ultrasound based screening test now exists with sufficient sensitivity and specificity to be utilised in the context of such a clinical trial. This article will set out the arguments for this proposal.

FACET

landfill

Screening for Ovarian Cancert an ultrasound based screening test now exists with sufficient sensitivity and specificity to be utilised in the context of such a clinical trial. This article will set out the arguments for this proposal.

homocysteine

Ovarian Carcinoma: Tumor- and Molecular Biologyf these genes might sufficiently perturb normal ovarian epithelial cell proliferation and differentiation to produce benign, borderline, and invasively-ma- lignant neoplasms from normal surface epithelium.

領(lǐng)導(dǎo)權(quán)

Cellular DNA Content as a New Prognostic Tool in Patients with Borderline Tumors of the Ovary. A Secer than the other types. Cellular atypia have been suggested of prognostic importance in borderline tumors [Russel 1984], but such grading is highly subjective and difficult to reproduce and standardize and not clearly related to the clinical outcome and therefore of limit value in prediction of individualized prognosis [3, 4, 5].

領(lǐng)導(dǎo)權(quán)

P. E. Hydon,T. Higenbottam,T. J. Pedley. Chemotherapy therefore may be given for several months without knowing whether the residual tumor is regressing or progressing. In this setting a tumor marker, which accurately reflects tumor burden, would improve the management of ovarian cancer by preventing ineffective treatment mostly accompanied by severe toxicity.

FLIRT

Prognosis

CORD

Die flowzytometrische Bestimmung des nukle?ren DNA-Gehaltes bei malignen epithelialen Tumoren der Ovstes? im Rahmen der Prim?roperation. So liegt es nahe, nach einem Faktor zu suchen, der rasch und objektiv, jederzeit auch von anderen Untersuchern aus dem gleichen Material reproduzierbar, Aussagen über den weiteren klinischen Verlauf bei einer individuellen Patientin zul??t.